<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0020201"><a href="http://purl.obolibrary.org/obo/MONDO_0020201">MONDO:0020201</a></h3>
<p><strong>Label:</strong> conjunctival telangiectasia (disease)</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0019180">MONDO:0019180</a> (hereditary hemorrhagic telangiectasia), <a href="http://purl.obolibrary.org/obo/MONDO_0008840">MONDO:0008840</a> (ataxia telangiectasia),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_100">Orphanet:100</a>, <a href="http://purl.obolibrary.org/obo/OMIM_601101">OMIM:601101</a>, <a href="http://purl.obolibrary.org/obo/OMIM_208910">OMIM:208910</a>, <a href="http://purl.obolibrary.org/obo/OMIM_208900">OMIM:208900</a>, <a href="http://purl.obolibrary.org/obo/OMIM_187300">OMIM:187300</a>, <a href="http://purl.obolibrary.org/obo/OMIM_600376">OMIM:600376</a>, <a href="http://purl.obolibrary.org/obo/OMIM_610655">OMIM:610655</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615506">OMIM:615506</a>, <a href="http://www.orpha.net/ORDO/Orphanet_774">Orphanet:774</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0004406">HP:0004406</a> (Spontaneous, recurrent epistaxis) and <a href="http://purl.obolibrary.org/obo/HP_0011276">HP:0011276</a> (Vascular skin abnormality) 72.22%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001009">HP:0001009</a> (Telangiectasia) and <a href="http://purl.obolibrary.org/obo/HP_0004406">HP:0004406</a> (Spontaneous, recurrent epistaxis) 72.22%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000006">HP:0000006</a> (Autosomal dominant inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0004406">HP:0004406</a> (Spontaneous, recurrent epistaxis) 72.22%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0004406">HP:0004406</a> (Spontaneous, recurrent epistaxis) 72.22%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004406">HP:0004406</a> (Spontaneous, recurrent epistaxis) and <a href="http://purl.obolibrary.org/obo/HP_0011025">HP:0011025</a> (Abnormality of cardiovascular system physiology) and <a href="http://purl.obolibrary.org/obo/HP_0011276">HP:0011276</a> (Vascular skin abnormality) 72.22%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001009">HP:0001009</a> (Telangiectasia) and <a href="http://purl.obolibrary.org/obo/HP_0004406">HP:0004406</a> (Spontaneous, recurrent epistaxis) and <a href="http://purl.obolibrary.org/obo/HP_0011025">HP:0011025</a> (Abnormality of cardiovascular system physiology) 72.22%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000006">HP:0000006</a> (Autosomal dominant inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0004406">HP:0004406</a> (Spontaneous, recurrent epistaxis) and <a href="http://purl.obolibrary.org/obo/HP_0011354">HP:0011354</a> (Generalized abnormality of skin) 72.22%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000006">HP:0000006</a> (Autosomal dominant inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0004406">HP:0004406</a> (Spontaneous, recurrent epistaxis) and <a href="http://purl.obolibrary.org/obo/HP_0011276">HP:0011276</a> (Vascular skin abnormality) 72.22%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000006">HP:0000006</a> (Autosomal dominant inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0004406">HP:0004406</a> (Spontaneous, recurrent epistaxis) and <a href="http://purl.obolibrary.org/obo/HP_0011121">HP:0011121</a> (Abnormality of skin morphology) 72.22%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000006">HP:0000006</a> (Autosomal dominant inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0001009">HP:0001009</a> (Telangiectasia) and <a href="http://purl.obolibrary.org/obo/HP_0004406">HP:0004406</a> (Spontaneous, recurrent epistaxis) 72.22%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000006">HP:0000006</a> (Autosomal dominant inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0000951">HP:0000951</a> (Abnormality of the skin) and <a href="http://purl.obolibrary.org/obo/HP_0004406">HP:0004406</a> (Spontaneous, recurrent epistaxis) 72.22%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0004406">HP:0004406</a> (Spontaneous, recurrent epistaxis) and <a href="http://purl.obolibrary.org/obo/HP_0011354">HP:0011354</a> (Generalized abnormality of skin) 72.22%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0004406">HP:0004406</a> (Spontaneous, recurrent epistaxis) and <a href="http://purl.obolibrary.org/obo/HP_0011276">HP:0011276</a> (Vascular skin abnormality) 72.22%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0004406">HP:0004406</a> (Spontaneous, recurrent epistaxis) and <a href="http://purl.obolibrary.org/obo/HP_0011121">HP:0011121</a> (Abnormality of skin morphology) 72.22%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000005">HP:0000005</a> (Mode of inheritance) and <a href="http://purl.obolibrary.org/obo/HP_0001009">HP:0001009</a> (Telangiectasia) and <a href="http://purl.obolibrary.org/obo/HP_0004406">HP:0004406</a> (Spontaneous, recurrent epistaxis) 72.22%</li>
</ul>
</body>
</html>
